Closing Bell: Knight Therapeutics Inc down on Monday (GUD)
Knight Therapeutics Inc opened trading today at $5.63 and closed at $5.62. It traded at a low of $5.54 to a high of $5.69.
Share prices eased -1.58 percent from the previous day's close of $5.71.
Today across North America, the TSX Composite closed -0.15% at 22779.57, the S&P 500 closed 1.11% at 5459.10, the Dow Jones Industrial Average closed 1.64% at 40589.34 and the Nasdaq Composite closed 1.03% at 17357.88.
Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).
Trading volume was 45,487 on 264 total trades. On average, Knight Therapeutics Inc has traded 40,497 shares over 5 days and 65,362 year-to-date.
The TSX overall saw 1,903 price advancers against 3,356 declines and 91 unchanged.
During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have boosted 16.84%, while they have boosted 8.29% since the start of 2024.
Following today's trading, Knight Therapeutics Inc has a market capitalization of $578.86 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.
Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.
Currently, Knight Therapeutics Inc has an average recommendation of "Moderate Buy" based on 4.00 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
